| 发明名称 |
MODIFIED RELEASE ORAL PHARMACEUTICAL COMPOSITION CONTAINING 5-ASA AND METHOD FOR THE TREATMENT OF BOWEL DISEASES |
| 摘要 |
<p>Modified release pharmaceutical composition and method for the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease and Colitis Ulcerosa, said compositions comprising as active the ingredient 5-aminosalicyclic acid (5-ASA), and being adapted for modified and targeted release so as to obtain a clinically important localized effect profile of 5-ASA by means of releasing an appropriate amount of 5-ASA in both the small and large bowel.</p> |
| 申请公布号 |
SI0871434(T1) |
申请公布日期 |
2002.04.30 |
| 申请号 |
SI19960030388T |
申请日期 |
1996.12.23 |
| 申请人 |
FARMACEUTISK LABORATORIUM FERRING A/S |
发明人 |
JEPSEN SVENN KLUEVER;HALSKOV SOEREN |
| 分类号 |
A61K9/16;A61K9/22;A61K9/50;A61K31/00;A61K31/60;A61K31/606;A61K47/38;A61P1/00;A61P1/04;A61P37/00;A61P37/06;(IPC1-7):A61K9/16 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
